385 related articles for article (PubMed ID: 28439048)
1. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
[TBL] [Abstract][Full Text] [Related]
2. Faecal Volatile Organic Compound Analysis in De Novo Paediatric Inflammatory Bowel Disease by Gas Chromatography-Ion Mobility Spectrometry: A Case-Control Study.
Vermeer E; Jagt JZ; Stewart TK; Covington JA; Struys EA; de Jonge R; de Boer NKH; de Meij TGJ
Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732837
[TBL] [Abstract][Full Text] [Related]
3. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis.
Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH
Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
[TBL] [Abstract][Full Text] [Related]
5. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
[TBL] [Abstract][Full Text] [Related]
6. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry.
Bosch S; El Manouni El Hassani S; Covington JA; Wicaksono AN; Bomers MK; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ
Anal Chem; 2018 Jul; 90(13):7972-7981. PubMed ID: 29860824
[TBL] [Abstract][Full Text] [Related]
7. Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.
Ahmed I; Greenwood R; Costello B; Ratcliffe N; Probert CS
Aliment Pharmacol Ther; 2016 Mar; 43(5):596-611. PubMed ID: 26806034
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD.
El Manouni El Hassani S; Bosch S; Lemmen JPM; Brizzio Brentar M; Ayada I; Wicaksono AN; Covington JA; Benninga MA; de Boer NKH; de Meij TGJ
Sensors (Basel); 2019 Oct; 19(20):. PubMed ID: 31623289
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.
Monasta L; Pierobon C; Princivalle A; Martelossi S; Marcuzzi A; Pasini F; Perbellini L
PLoS One; 2017; 12(8):e0184118. PubMed ID: 28859138
[TBL] [Abstract][Full Text] [Related]
11. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
[TBL] [Abstract][Full Text] [Related]
12. Faecal gas analysis by electronic nose as novel, non-invasive method for assessment of active and quiescent paediatric inflammatory bowel disease: Proof of principle study.
de Meij TG; de Boer NK; Benninga MA; Lentferink YE; de Groot EF; van de Velde ME; van Bodegraven AA; van der Schee MP
J Crohns Colitis; 2014 Sep; ():. PubMed ID: 25248313
[TBL] [Abstract][Full Text] [Related]
13. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.
de Meij TGJ; de Groot EFJ; Peeters CFW; de Boer NKH; Kneepkens CMF; Eck A; Benninga MA; Savelkoul PHM; van Bodegraven AA; Budding AE
PLoS One; 2018; 13(8):e0197649. PubMed ID: 30102706
[TBL] [Abstract][Full Text] [Related]
14. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.
Patel N; Alkhouri N; Eng K; Cikach F; Mahajan L; Yan C; Grove D; Rome ES; Lopez R; Dweik RA
Aliment Pharmacol Ther; 2014 Sep; 40(5):498-507. PubMed ID: 25041596
[TBL] [Abstract][Full Text] [Related]
16. Fecal Amino Acid Analysis Can Discriminate De Novo Treatment-Naïve Pediatric Inflammatory Bowel Disease From Controls.
Bosch S; Struys EA; van Gaal N; Bakkali A; Jansen EW; Diederen K; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):773-778. PubMed ID: 29112087
[TBL] [Abstract][Full Text] [Related]
17. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
De Preter V; Machiels K; Joossens M; Arijs I; Matthys C; Vermeire S; Rutgeerts P; Verbeke K
Gut; 2015 Mar; 64(3):447-58. PubMed ID: 24811995
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review.
Bannaga AS; Farrugia A; Arasaradnam RP
Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1113-1122. PubMed ID: 31657950
[No Abstract] [Full Text] [Related]
19. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
20. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
Aomatsu T; Imaeda H; Matsumoto K; Kimura E; Yoden A; Tamai H; Fujiyama Y; Mizoguchi E; Andoh A
Aliment Pharmacol Ther; 2011 Oct; 34(8):941-8. PubMed ID: 21848856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
